| Compound | Primary Target | Clinical Status | Approx. IC₅₀ (BRD4) | |----------|----------------|-----------------|----------------------| | | BRD4 BD1/BD2 | IND‑ready (2025) | 48 nM | | OTX‑015 (MK‑8628) | BRD4/BRD2 | Phase II (2022) | 55 nM | | JQ‑1 | BRD4/BRD2 | Pre‑clinical (tool) | 77 nM | | ABBV‑744 | BRD4 BD2 selective | Phase I (2023) | 120 nM (BD2) | | CPI‑0610 | BET family (pan) | Phase II (2024) | 30 nM (BRD4) |
The film stars Rena Momozono (桃園怜奈) , a popular performer in the industry known for her "I-cup" bust size. JUFE-448
The "JUFE" prefix identifies the specific label under the studio. Fitch is known for producing high-definition content that targets niche categories such as big tits, lotion-based scenes, and solowork. JUFE-448 - Jav Trailers | Compound | Primary Target | Clinical Status | Approx
Because JUFE‑448 is moderately lipophilic and suffers from limited aqueous solubility, several formulation approaches have been explored: Fitch is known for producing high-definition content that
– The core scaffold is patented globally (CN, US, EP, JP). Companies wishing to develop analogues must either license the core or design around the protected substitution pattern (e.g., varying the phenyl‑pyridine linkers). The patents have a typical 20‑year term; the earliest expiration is projected for 2042 (US filing).
Based on current technical and industrial databases, "JUFE-448" does not appear as a standard industry-wide code or a widely recognized academic course in major repositories. It may refer to one of the following: A Specialized Internal Code